CAGE Bio begins double-blind placebo-controlled clinical trial of topical DNA Aptamer therapy CGB-600 for vitiligo treatment: San Carlos, California Saturday, October 25, 2025, 12 ...
Incyte today announced new data from the Phase 3b TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib cream) in adults with moderate atopic dermatitis (AD) who had an ...
From how much sleep you are getting to whether you are eating the right diet, scientists say that hair holds the secrets to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback